Highlights of Ophthalmology

Register      Login

Table of Content

2012 | Feb-2012 | Volume 40 | Issue 1ENG

Total Views

REVIEW ARTICLE

Jamison Engle, Uday Devgan

The Impact of Femtosecond Laser Technology in Cataract Surgery

[Year:2012] [Month:Feb-2012] [Volume:40] [Number:1ENG] [Pages:4] [Pages No:2 - 5]

   DOI: 10.5005/hoo-10101-40101  |  (Buy Now)  |  How to cite  | 

114

REVIEW ARTICLE

Dhivya Ashok Kumar, Soosan Jacob, Amar Agarwal

Intraocular Lens (IOL) as a Scaffold to Prevent Nucleus Drop

[Year:2012] [Month:Feb-2012] [Volume:40] [Number:1ENG] [Pages:6] [Pages No:6 - 11]

   DOI: 10.5005/hoo-10101-40102  |  (Buy Now)  |  How to cite  | 

146

REVIEW ARTICLE

Jeffrey M. Goshe

Management of Complications in DSAEK - Personal Recommendations

[Year:2012] [Month:Feb-2012] [Volume:40] [Number:1ENG] [Pages:3] [Pages No:13 - 15]

   DOI: 10.5005/hoo-10101-40103  |  (Buy Now)  |  How to cite  | 

77

REVIEW ARTICLE

Heloisa Andrade Maestrini, Carlos Akira Omi

Managing Failing Blebs after Trabeculectomy

[Year:2012] [Month:Feb-2012] [Volume:40] [Number:1ENG] [Pages:4] [Pages No:16 - 19]

   DOI: 10.5005/hoo-10101-40104  |  (Buy Now)  |  How to cite  | 

70

REVIEW ARTICLE

Jose M. Ruiz-Moreno, Javier A. Montero, Pedro Amat-Peral, Francisco L. Lugo

Bevacizumab and Cataract Surgery in AMD

[Year:2012] [Month:Feb-2012] [Volume:40] [Number:1ENG] [Pages:5] [Pages No:20 - 24]

   DOI: 10.5005/hoo-10101-40105  |  (Buy Now)  |  How to cite  | 

Abstract

Introduction: Inflammatory mediators such as those released by surgery may induce choroidal neovasculari- zation (CNV) re-activation. We report the use of intravitreal bevacizumab associated with cataract surgery to prevent CNV re-activation in patients with previously treated CNV associated with Age Related Macular Degeneration (AMD). Patients and Methods: Interventional case series of fourteen eyes from 14 patients presenting cataracts who had been previously treated for wet AMD. The patients underwent clear cornea phacoemulsification with intraocular lens implantation. An intravitreal injection of 1.25 mg (0.05 ml) bevacizumab was performed by the end of the procedure. The historical data of nine patients previously treated for wet AMD who had undergone cataract surgery at our hospital were used as control group. The results were evaluated in terms of visual acuity improvement and reactivation of CNV as determined by the appearance of fluid in optical coherence tomography (OCT). Results: Best corrected visual acuity (BCVA) significantly improved after surgery (p=0.000, Student t test for paired data). Mean follow-up after cataract surgery was 13.5 months (SD 6.5, range 6 to 25 months). CNV re-activation or new CNV lesions were not observed in any case during follow-up in the treated group. CNV re- activation was observed in two cases at 4 and 6 months after cataract surgery in the control group. Conclusion: Intravitreal bevacizumab injected immediately after cataract surgery may prevent CNV re-activation in patients with previously treated CNV secondary to AMD.

117

© Jaypee Brothers Medical Publishers (P) LTD.